COBIOE
CEBR Projects
Location:
Europe
Project duration:
Jan 2023 – Jun 2025
Funding Acknowledgment:
This project has received funding from the European Union under Grant Agreement No. 10109512.
About
COBIOE is a European funded project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support.
Specifically, the proposition is focused on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…).
The project aims to interconnect bioproduction ecosystems, which includes small molecules, innovative therapeutics, high-tech medicines based on cellular and molecular biology, and covers various applications in the health sector (oncology, immunology, virology, rare diseases, etc…), to converge on a common strategy for this segment.
One of the main objectives of the project is to build a digital platform to:
- Provide an overview of this segment in Europe
- Promote new opportunities for collaboration between European actors
- Advocate bioproduction and its potential in terms of green, digital and social transition to various stakeholders and political decision-makers
Our Concept
This dynamic digital platform serves as a comprehensive reference point for stakeholders spanning the entire value chain. From research and development to advanced therapies, clinical validation, bioproduction, and market access—our platform unites diverse bioproduction ecosystems.
Our key objectives
- Strengthening European industrial bioproduction capacities.
- Simplifying access to both public and private fundings.
- Amplifying the industrialization and production of biomedicines within Europe.
- Strenghten investments in industrial process and technology development.
- Accelerating research and innovation for groundbreaking treatments.
- Addressing competency gaps by nurturing skills, attracting talents, and retaining experts.
- Elevating productivity through enhanced innovation yields and reduced production costs.
Project Partners:
